AEGiS-NV: HIV: Babies can be tested at 4 weeks The New Vision (Uganda)Important note: Information in this article was accurate in 2007. The state of the art may have changed since the publication date.
Click here to return to The New Vision main menu
DonateNow
Print this Article


HIV: Babies can be tested at 4 weeks

New Vision (Kampala) - August 24, 2007
Conan Businge


MULAGO Hospital and Uganda Virus Institute have acquired new machines that will enable babies as young as one month to be tested for HIV.

Previously, babies could only be tested at the age of 18 months. This was revealed by Mildmay Centre director Dr. Emmanuel Luyirika, during a breakfast meeting at Sheraton Hotel, Kampala on Wednesday.

This will greatly reduce the infant mortality rate, which was partly caused by the failure to test the HIV virus early enough.

"There is a big number of HIV positive mothers in this country, but they are few of them who endeavour to carry out HIV testing of their babies. Several babies die of AIDS before the age of 18 months," Luyirika said.

He added that currently, the infants' testing services are being offered at Mildmay, in conjunction with Mulago Hospital.

Dr. William Musoke of Mildmay Centre, said at four weeks, the tests are done on antigens and not anti-bodies of the infants.

He explained: "Children below 18 months use the antibodies of their mothers and if the mother tests HIV positive, so will the child. It is for this reason, that we test antigens at this age (four weeks), because they can never resemble, those of the infant's mother."

He, however, added that it is important to carry out another test of antibodies at the age of 18 months.

Antibodies are proteins that are found in blood or other bodily fluids of vertebrates and are used by the immune system to identify and neutralise foreign objects, such as bacteria and viruses An antigen is a molecule that stimulates an immune response.

The word originated from the notion that they can stimulate antibody generation.


070824
NV070823


Copyright © 2007 - The New Vision. All articles are republished on AEGIS by permission. Material may not be redistributed, posted to any other location, published or used for broadcast without written authorization from Managing Director/Editor-in-chief, The New Vision, P.O. Box 9815, Kampala - Uganda, Tel/fax: 256-41-235221, E-mail: wpike@newvision.co.ug.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, the National Library of Medicine, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 2007. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2007. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .